Chronic migraine and medication-overuse headache through the ages

Cephalalgia

Volumn 25, Issue 5, 2005, Pages 378-390

  Boes, Christopher J ^a   Capobianco, D J ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Analgesic overuse headache; Chronic migraine; Ergotamine overuse headache; Medication overuse headache; Transformed migraine

Indexed keywords

ERGOTAMINE;

CLINICAL PROTOCOL; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DRUG OVERDOSE; DRUG WITHDRAWAL; HISTORY OF MEDICINE; HUMAN; MIGRAINE; REVIEW; STATISTICAL ANALYSIS; TRANSFORMED MIGRAINE;

ERGOTAMINES; HEADACHE DISORDERS; HISTORY, 17TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MIGRAINE DISORDERS; PORTRAITS;

EID: 17644406405     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.00868.x     Document Type: Review

References (56)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004; 24 (Suppl. 1):1-160.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
3. Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meetings Mayo Clinic 1951; 26:153-61.
4. Isler H. A hidden dimension in headache work: applied history of medicine. Headache 1986; 26:27-9.
5. Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstandings. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988:87-94.
6. Kielholz P. Abusus und Sucht mit phenacetinhaltigen Kombinationsprä paraten. Schweiz Med Wochenschr 1957; 87:1131-4.
7. Wörz R, Baar H, Draf W, Garcia J, Gerbershagen HU, Gross D et al. Kopfschmerz in Abhängigkeit von Analgetika-Mischpräparaten. Münch Med Wschr 1975; 117:457-62.
8. Wörz R. Abuse and paradoxical effects of analgesic drug mixtures. Br J Clin Pharmacol 1980; 10 (Suppl. 2):391S-393S.
9. Kudrow L. Paradoxical effects of frequent analgesic use. In: Critchley M, Friedman A, Goroni S, Sicuteri F, editors. Advances in neurology. New York: Raven Press, 1982; 33:335-41.
10. Isler H. Migraine treatment as a cause of chronic migraine. In: Rose FC editor. Advances in migraine research and therapy. New York: Raven Press, 1982:159-64.
11. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982; 22:66-8.
12. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27:102-6.
13. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327:1109-14.
14. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34:1-7.
15. Osborne MJ, Austin RCT, Dawson KJ, Lange L. Drug points: is there a problem with long term use of sumatriptan in acute migraine? Br Med J 1994; 308:113.
16. Kaube H, May A, Diener H-C, Pfaffenrath V. Sumatriptan. Br Med J 1994; 308:1573-4.
17. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47:871-5.
18. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13:277-83.
19. McHenry LC. The seventeenth century. In Garrison's history of neurology: revised and enlarged with a bibliography of classical, original and standard works in neurology. Springfield, IL: Charles C. Thomas, 1969:53-89.
20. Spillane JD. Willis and the nervous system. In The doctrine of the nerves. Chapters in the history of neurology. London: Oxford University Press, 1981:53-107.
21. Critchley M. The malady of Anne, Countess Conway: a case for commentary. King's College Hospital Gazette 1937; 17:44-9.
22. Weil A. Hermann Oppenheim (1858-1919). In Haymaker W editor. The founders of neurology. Springfield, IL: Charles C. Thomas, 1953:343-6.
23. Oppenheim H. Diseases of the nervous system. A textbook for students and practitioners of medicine. Philadelphia: J.B. Lippincott, 1900.
24. Critchley M. James Collier (1870-1935). In: The black hole and other essays. London: Pitman, 1964:115-23.
25. Russell JSR, Batten FE, Collier JS. Subacute combined degeneration of the spinal cord. Brain 1900; 23:39-110.
26. Collier J. Diseases of the nervous system. In Price FW editor. A textbook of the practice of medicine. London: Hodder and Stoughton, 1922:1502-6.
27. von Storch TJC. The migraine syndrome: comments on its diagnosis, etiology and treatment. N Engl J Med 1937; 217:247-51.
28. Balyeat R. Migraine: diagnosis and treatment. Philadelphia: J.B. Lippincott, 1933.
29. Offen ML. Dealing with 'defectives'. Foster Kennedy and William Lennox on eugenics. Neurology 2003; 61:668-73.
30. Lennox WG. Science and seizures. New light on epilepsy and migraine. New York: Harper and Brothers, 1941.
31. Dejong R. A history of American neurology. New York: Raven Press, 1982.
32. Lennox WG. The use of ergotamine tartrate in migraine. N Engl J Med 1934; 210:1061-5.
33. O'Sullivan ME. Termination of one thousand attacks of migraine with ergotamine tartrate. JAMA 1936; 107:1208-12.
34. Kirstein L, Silfverskiöld BP. A family with emotionally precipitated drop seizures. Acta Psychiatr Neurol Scand 1958; 33:471-6.
35. Ryan SG, Sherman SL, Terry JC, Sparkes RS, Torres MC, Mackey RW. Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosone 5q by linkage analysis. Ann Neurol 1992; 31:663-8.
36. Silfverskiöld BP. Gynergen abuse in cases of migraine. Acta Psychiat Neurol 1947; 46 (Suppl.):281-5.
37. Capobianco DJ, Swanson JW, Dodick DW. Medication-induced (analgesic rebound) headache: historical aspects and initial descriptions of the North American experience. Headache 2001; 41:500-2.
38. Horton BT, Peters GA. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963; 3:214-26.
39. Dalessio DJ. Obituary: John R Graham, MD. Cephalalgia 1990; 10:156.
40. Spierings ELH. Tribute to John Ruskin Graham, MD, MACP. Headache 1988; 28:652-3.
41. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiat 1938; 39:737-63.
42. Graham JR. Methysergide for prevention of headache; experience in five hundred patients over three years. N Engl J Med 1964; 270:67-72.
43. Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 1966; 274:359-68.
44. Spierings ELH. Migraine, big and small. Headache 2001; 41:918-20.
45. Graham JR. Treatment of migraine. Boston: Little, Brown, 1955.
46. Graham JR. Migraine: clinical aspects. In Vinken PJ, Bruyn GW editors. Handbook of clinical neurology, Chapter 5, Headaches and cranial neuralgias. Amsterdam: North-Holland, 1968:45-58.
47. Lippman CW. Certain hallucinations peculiar to migraine. J Nerv Ment Dis 1952; 116:346-51.
48. Rolak LA. Literary neurologic syndromes: Alice in Wonderland. Arch Neurol 1991; 48:649-51.
49. Lippman CW, Lippman M. Understanding your migraine headache. New York: Greenberg, 1952.
50. Lippman CW. Characteristic headache resulting from prolonged use of ergot derivatives. J Nerv Ment Dis 1955; 121:270-3.
51. Solomon S. Arnold P Friedman 1909-1990. Headache 1991; 31:286-7.
52. The Ad Hoc Committee on Classification of Headache. Classification of headache. Arch Neurol 1962; 6:173-6.
53. Friedman AP, Brazil P, von Storch TJC. Ergotamine tolerance in patients with migraine. JAMA 1955; 157:881-4.
54. Friedman AP, Merritt HH. Migraine. In Friedman AP, Merritt HH editors. Headache: diagnosis and treatment. Philadelphia: FA Davis, 1959:201-49.
55. Lipton RB, Stewart WF, Cady R, Hall C, O'Quinn S, Kuhn T et al. Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache 2000; 40:783-91.
56. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506.